Experimental arthritis drug may help prevent severe Covid-19 in high-risk group

Experimental arthritis drug ‘may help prevent severe Covid-19 in the high risk’ (Peter Byrne/PA)

An experimental arthritis drug could help prevent severe Covid-19 in those at highest risk from the disease, research suggests.

Otilimab demonstrated a potential clinical benefit in people aged between 70 and 80 over and above the current standard of care, the study indicated.